Torrent Pharmaceuticals gets observations from USFDA for Indrad plant

26 Apr 2019 Evaluate

Torrent Pharmaceuticals has received certain observations from the US Food and Drug Administration (USFDA) for Indrad Plant which are procedural in nature and the company is confident of addressing them satisfactorily. The audit at Indrad Plant of the company was carried out by USFDA in the month of April, 2019.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3757.45 -23.45 (-0.62%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×